Dibucaine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for dibucaine hydrochloride and what is the scope of patent protection?
Dibucaine hydrochloride
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for dibucaine hydrochloride
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 91 |
Patent Applications: | 2,629 |
DailyMed Link: | dibucaine hydrochloride at DailyMed |
Medical Subject Heading (MeSH) Categories for dibucaine hydrochloride
US Patents and Regulatory Information for dibucaine hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | HEAVY SOLUTION NUPERCAINE | dibucaine hydrochloride | INJECTABLE;INJECTION | 006203-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |